GH & Metabolic Stack GH & Metabolic Stack STACK IMAGE
BATCH COA SUPPLIED HPLC VERIFIED RESEARCH USE ONLY
— STACK · 2 COMPOUNDS

GH & Metabolic Stack Retatrutide + Tesamorelin

For in vitro research use only. GH & Metabolic Stack is not for human or veterinary consumption, diagnosis, treatment, or prevention of any condition.

Research bundle pairing two compounds investigated across metabolic and growth hormone pathways. Retatrutide simultaneously engages GLP-1, GIP, and glucagon receptors in metabolic regulation research; Tesamorelin is a clinically researched GHRH analogue studied for GH secretion, IGF-1 pathway activity, and visceral fat distribution.

Research overview

Research bundle pairing two compounds investigated across metabolic and growth hormone pathways. Retatrutide simultaneously engages GLP-1, GIP, and glucagon receptors in metabolic regulation research; Tesamorelin is a clinically researched GHRH analogue studied for GH secretion, IGF-1 pathway activity, and visceral fat distribution. Together they provide coverage of the primary growth and metabolic signalling axes studied in preclinical research. Two individual lyophilised vials. For in vitro research use only.

Compounds in this stack

Retatrutide

GLP-1 / GIP / Glucagon Triple Agonist

A synthetic peptide that simultaneously activates three distinct metabolic receptors — GLP-1, GIP, and glucagon — each involved in regulating energy balance, insulin response, and fat metabolism. By engaging all three pathways at once, it offers researchers a tool for studying multi-receptor metabolic signalling in ways that single-agonist compounds cannot.

98.8% HPLC View Retatrutide →

Tesamorelin

Growth Hormone Releasing Factor Analogue

A synthetic analogue of the full-length growth hormone-releasing hormone (GHRH), with structural modifications that slow its breakdown and extend its active window. Investigated in preclinical and clinical research for its effects on GH and IGF-1 production, and studied in specific patient groups for its influence on visceral fat distribution.

CAS 218949-48-9 98.6% HPLC View Tesamorelin →

For in vitro research use only. This stack is supplied solely as research reagents for qualified professionals conducting in vitro or animal-model studies. No compound in this stack is a medicinal product. None has been evaluated by the MHRA or FDA. None is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition.

Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.